Anixa Biosciences
ANIX· Manufacturing· Fiscal year ends in October
CEO pay in FY2025Stock +18.0% in FY2025
Dr. Amit Kumar is the CEO of Anixa Biosciences and was paid $2.5M in FY2025 (Oct), down 27%.
Pay$100 in the stock at the end of FY21 → $87
Executives2
See all- 1Dr. Amit KumarChairman of the Board and Chief Executive OfficerFY2025
- 2Michael J. CatelaniPresident, Chief Operating Officer and Chief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAnixa Biosciences paid its 2 named executives $3.8M in total in FY2025 (Oct). CEO Dr. Amit Kumar was paid $2.5M of that.
| Name | |||
|---|---|---|---|
| Dr. Amit KumarChairman of the Board and Chief Executive Officer | |||
| Michael J. CatelaniPresident, Chief Operating Officer and Chief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Anixa Biosciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Jan 28, 2026 | FY2025 |
| Annual report | 10-K | Jan 12, 2026 | FY2025 |
| Proxy statement | DEF 14A | Feb 6, 2025 | FY2024 |
| Annual report | 10-K | Jan 10, 2025 | FY2024 |
| Proxy statement | DEF 14A | Feb 8, 2024 | FY2023 |
| Annual report | 10-K | Jan 16, 2024 | FY2023 |